d-alpha tocopherol has been researched along with Liver Cirrhosis in 107 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (20.56) | 18.7374 |
| 1990's | 16 (14.95) | 18.2507 |
| 2000's | 31 (28.97) | 29.6817 |
| 2010's | 24 (22.43) | 24.3611 |
| 2020's | 14 (13.08) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, NPH; Cheng, FWT; Chow, TTW; Chu, WCW; Feng, J; Lam, GKS; Leung, AWK; Li, CK; Ng, MHL | 1 |
| Nishino, H | 2 |
| Ackerman, Z; Grozovski, M; Oron-Herman, M; Pappo, O; Peleg, E; Safadi, R; Schmilovitz-Weiss, H | 1 |
| Babany, G; Bonny, C; Chevallier, M; Cheveau, A; Desmorat, H; Melin, P; Pinta, A; Raabe, JJ; Rouanet, S; Sogni, P; Sturm, N; Zarski, JP | 1 |
| PAPPENHEIMER, AM; VICTOR, J | 1 |
| Abhilash, PA; Das, SS; Harikrishnan, R; Indira, M; Prathibha, P; Rejitha, S | 1 |
| Bedossa, P | 1 |
| Itoshima, T; Kawaguchi, M; Okita, M; Osawa, T; Ota, Y; Sakai, N; Sasagawa, T; Tomioka, K | 1 |
| DIOGUARDI, N; SECCHI, GC | 1 |
| VALAGUSSA, L | 1 |
| Hashimoto, Y; Kabeya, K; Kakizaki, S; Kaneko, M; Konaka, K; Mori, M; Nagamine, T; Sato, K; Shimojo, H; Sohara, N; Tago, Y; Takagi, H; Takahashi, H; Takayama, H; Tsukioka, G; Yamada, T | 1 |
| Barreto, R; Marotta, F; Naito, Y; Packer, L; Yoshida, C | 1 |
| Berhe, N; Blomhoff, R; Gundersen, SG; Gundersen, TE; Halvorsen, BL; Myrvang, B | 1 |
| Hasegawa, T; Makino, I; Nakamura, K; Terano, A; Yoneda, M | 1 |
| Hasuda, K; Okita, M; Ota, Y; Sasagawa, T; Suzuki, K; Tomioka, K; Watanabe, A | 1 |
| Camps, J; Ferré, N; Girona, J; Gómez, F; Heras, M; Joven, J; Prats, E; Ribalta, J; Simó, JM | 1 |
| Bernardi, M; Caraceni, P; Dazzani, F; Domenicali, M; Grazi, G; Guarnieri, C; Micati, M; Nardo, B; Simoncini, M; Stefanelli, C; Trevisani, F; Zambruni, A | 1 |
| Aveyard, P; Cobbold, JF; Heath, L; Koutoukidis, DA; Tomlinson, JW | 1 |
| Cammà, C; Celsa, C; Ciccioli, C; Craxì, A; Di Marco, V; Enea, M; Infantino, G; La Mantia, C; Parisi, S; Pennisi, G; Petta, S; Vaccaro, M; Vernuccio, F | 1 |
| Alisi, A; Bianchi, M; Braghini, MR; Comparcola, D; Condorelli, AG; Conti, LA; Crudele, A; De Stefanis, C; Gurrado, F; Lioci, G; Mosca, A; Nobili, R; Panera, N; Sartorelli, MR; Scoppola, V; Smeriglio, A; Svegliati-Baroni, G; Trombetta, D | 1 |
| Alexander, L; Behling, C; Biegel, H; Chalasani, N; Dasarathy, S; Diehl, AM; Hameed, B; Jia, Y; Karpen, SJ; Kleiner, DE; Kowdley, KV; Lavine, JE; Loomba, R; Neuschwander-Tetri, BA; Ostroff, R; Sanyal, AJ; Tonascia, J; Williams, J; Williams, SA; Yates, KP | 1 |
| Nakajima, A; Ogawa, Y; Okanoue, T; Sumida, Y; Yoneda, M | 1 |
| Atkin, SL; De Vincentis, A; Jamialahmadi, T; Mahjoubin-Tehran, M; Mantzoros, CS; Mikhailidis, DP; Sahebkar, A | 1 |
| Kohli, R; Lin, CH | 1 |
| Bader, AR; Jeske, R; Westfall, E | 1 |
| Azam, M; Baig, MT; Ghufran, H; Humayun, S; Mehmood, A; Riazuddin, S | 1 |
| Seen, S | 1 |
| Chalasani, N; Cummings, OW; Gawrieh, S; Harlow, KE; Molleston, JP; Pike, F; Rosenberg, WM; Wilson, LA; Yates, KP | 1 |
| Barnard, A; Dave, S; Loomba, R; Majzoub, AM; Munaganuru, N; Murad, MH; Nayfeh, T; Singh, S | 1 |
| Banini, BA; Sanyal, AJ | 1 |
| Katsinelos, P; Kountouras, J; Mantzoros, CS; Polymerou, V; Polyzos, SA | 1 |
| Fleet, SE; Lavine, JE; Lefkowitch, JH | 1 |
| Issa, D; Patel, V; Sanyal, AJ | 1 |
| Chaiyakunapruk, N; Chongmelaxme, B; Dilokthornsakul, P; Phisalprapa, P; Sawangjit, R | 1 |
| Chalasani, N; Cummings, OW; Gawrieh, S; Ghabril, M; Saxena, R; Vilar-Gomez, E; Vuppalanchi, R | 1 |
| Brunt, EM; Kleiner, DE; Neuschwander-Tetri, BA; Sanyal, AJ; Wilson, LA | 1 |
| Brunner, KT; Henneberg, CJ; Long, MT; Wilechansky, RM | 1 |
| Byrne, CD; Jennison, E; Patel, J; Scorletti, E | 1 |
| Adly, AA; Attia, AA; Elalfy, MS; Ibrahim, FA; Mohammed, AS; Sayed, AM | 1 |
| Abdelazim, SA; Ali, SA; Darwish, HA; Kadry, MO; Rizk, MZ | 1 |
| Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Munda, P; Rechling, C; Trauner, M; Traussnigg, S | 1 |
| Dufour, JF; Perazzo, H | 1 |
| Oseini, AM; Sanyal, AJ | 1 |
| Farrell, G; George, J; Hou, JY; Leclercq, I; Pera, N; Phung, N | 1 |
| Lavine, JE; Mencin, AA | 1 |
| Álvarez Ferre, J; González Jiménez, E; Schmidt Río-Valle, J | 1 |
| Chandok, N; Marotta, P; Shankar, N; Tan, P; Uhanova, J | 1 |
| Du, J; Hu, Y; Lu, J; Wang, X; Xu, L; Ye, S; Zhang, R | 1 |
| Grønbæk, H; Heebøll, S; Kazankov, K; Poulsen, MK; Vilstrup, H | 1 |
| Brunt, EM; Chalasani, N; Charlton, M; Cusi, K; Diehl, AM; Lavine, JE; Sanyal, AJ; Younossi, Z | 1 |
| Craig, JC; George, J; Mahady, SE; Wong, G | 1 |
| Chang, HM; Chien, CT; Hung, GD; Lee, HS; Lee, KL; Li, PC | 1 |
| Chen, H; Wang, Y; Wei, L; Zhan, Y | 1 |
| PETZOLD, H; WEBER, L | 1 |
| Harrison, SA; Hayashi, P; Schenker, S; Torgerson, S; Ward, J | 1 |
| Cai, JT; Lu, XL; Qian, KD; Zhang, ZL; Zhou, JF | 1 |
| Moreno, MG; Muriel, P | 1 |
| KLATSKIN, G; MOLANDER, DW | 1 |
| Harrison, SA; Schenker, S; Ward, JA | 1 |
| Bugianesi, E; David, E; Gentilcore, E; Manini, R; Marchesini, G; Natale, S; Rizzetto, M; Vanni, E; Villanova, N | 1 |
| Bandara, P; Byth, K; Farrell, GC; George, J; Kench, J; Lux, O; McCaughan, G; Naidoo, D; Salonikas, C | 1 |
| D'Auria, M; de Sio, I; Di Leva, A; Federico, A; Loguercio, C; Niosi, M; Trappoliere, M; Tuccillo, C | 1 |
| Bendia, E; Benedetti, A; Candelaresi, C; De Minicis, S; Di Sario, A; Marzioni, M; Omenetti, A; Taffetani, S | 1 |
| Balasubramanian, KA; Basivireddy, J; Kang, G; Natarajan, SK; Pulimood, AB; Ramachandran, A; Ramamoorthy, P; Thomas, S | 1 |
| Borojevic, R; Dal-Pizzol, F; Franceschi, MF; Grivicich, I; Guaragna, RM; Guimarães, EL; Guma, FC; Margis, R; Moreira, JC | 1 |
| Kadayifci, A; Merriman, RB | 1 |
| Altaner, S; Aydogdu, N; Baloglu, H; Basaran, UN; Dokmeci, G; Gedik, N; Kaymak, K; Kutlu, K; Soylu, AR; Tarcin, O; Tezel, A; Ture, M; Umit, H | 1 |
| Bihl, F; Cereda, JM; Cerny, A; Dufour, JF; Gonvers, JJ; Helbling, B; Oneta, CM; Steuerwald, M; Zala, JF; Zimmermann, A | 1 |
| Barve, S; Cave, M; Deaciuc, I; Joshi-Barve, S; McClain, C; Mendez, C; Song, Z | 1 |
| Benedetti, A; Candelaresi, C; Di Sario, A; Omenetti, A | 1 |
| Bertini, E; Boldrini, R; Ciacco, E; Devito, R; Gaeta, LM; Marcellini, M; Nobili, V; Petrini, S; Piemonte, F; Tozzi, G | 1 |
| Takahashi, Y | 1 |
| Ball, CJ; Brickley, JJ; Greenwood, RS; Messenheimer, JA; Tennison, MB | 1 |
| Kondo, M; Takemura, S; Yoshikawa, T | 1 |
| Konikoff, F | 1 |
| Bernard, O; Estrada, A; Hadchouel, M; Jacquemin, E; Maggiore, G; O'Connell, NC; Schmitz, J; Setchell, KD | 1 |
| Yamamoto, Y; Yamashita, S | 2 |
| Basili, S; Camastra, C; Cordova, C; Ferro, D; FitzGerald, GA; Iuliano, L; Pratico, D; Violi, F | 1 |
| Carloni, V; Fabrizio, P; Galli, C; Gentilini, P; Laffi, G; Marra, F; Melani, L; Riccardi, D; Spadoni, S; Tosti-Guerra, C | 1 |
| Fujisawa, A; Kokura, S; Yamamoto, Y; Yamashita, S; Yoshikawa, T | 1 |
| Hahn, C; Look, MP; Rao, GS; Reichel, C; Sauerbruch, T; Spengler, U; Stockinger, K; von Bergmann, K; von Falkenhausen, M | 1 |
| Basili, S; Ferro, D; FitzGerald, GA; Iuliano, L; Praticó, D; Violi, F | 1 |
| Bacher, H; Cerwenka, H; El-Shabrawi, A; Khoschsorur, G; Mischinger, HJ; Quehenberger, F; Rabl, H; Werkgartner, G | 1 |
| Chon, CY; Chung, JP; Han, KH; Lee, KS; Lee, SI; Lee, SJ; Moon, YM; Park, HJ | 1 |
| Cantürk, NZ; Cantürk, Z; Gelen, T; Ozbilim, G; Utkan, NZ; Yalman, Y; Yenisey, C | 1 |
| Aboutwerat, A; Burrows, PC; Jain, SK; McMahon, RF; Pemberton, PW; Smith, A; Warnes, TW | 1 |
| Hobara, N; Watanabe, A | 1 |
| Dítĕ, P; Fendrichová, M; Groh, J; Nerad, V; Skaunic, V | 1 |
| Bloom, AL; Khurshid, M; Lee, TJ; Peake, IR | 1 |
| Blache, D; Bouma, ME; Feldmann, G; Gay, G; Roche, JF; Scoazec, JY; Verthier, N | 1 |
| Bonkovsky, HL | 1 |
| Borghi, A; Casalgrandi, G; Paolillo, F; Pradelli, M; Rocchi, E | 1 |
| Harada, T; Kawase, T; Suzuki, T | 1 |
| Ben-Amitay, G; Fishel, B; Gilat, T; Halpern, Z; Konikoff, F; Rattan, J; Theodor, E; Weisman, Y | 1 |
| Abdullaev, GM; Zeĭnally, EM | 2 |
| Akesson, B; Berglund, M; Joelsson, B; Johansson, U; Johnsson, F | 1 |
| Chvapil, M | 1 |
| Dixon, MF; Kelleher, J; Losowsky, MS; Walker, BE | 1 |
| Akesson, B; Göransson, G; Nord'en, A | 1 |
| Davidson, CS; Kater, RM; Kim, CY; Unterecker, WJ | 1 |
| Kelleher, J; Losowsky, MS | 1 |
| Parkhurst, RM; Scholler, J; Schwarz, K; Skinner, WA | 1 |
| Davies, T; Kelleher, J; Losowsky, MS | 1 |
| Forattini, C; Pulliero, G | 1 |
20 review(s) available for d-alpha tocopherol and Liver Cirrhosis
| Article | Year |
|---|---|
[Fibrosis in chronic hepatitis C infection: mechanisms and cofactors].
Topics: Adult; Age Factors; Aged; Alcoholism; alpha-Tocopherol; Antiviral Agents; Biopsy; Child; Cicatrix; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Female; Hemochromatosis; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunohistochemistry; Inflammation; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Necrosis; Phenotype; Risk Factors; Sex Factors; Transforming Growth Factor beta | 2002 |
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis.
Topics: Drugs, Investigational; Humans; Liver; Liver Cirrhosis; Network Meta-Analysis; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Vitamin E | 2022 |
Current and new pharmacotherapy options for non-alcoholic steatohepatitis.
Topics: Chenodeoxycholic Acid; Clinical Trials as Topic; Fibroblast Growth Factors; Glucagon-Like Peptides; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Vitamin E | 2020 |
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis.
Topics: Biopsy; Disease Progression; Humans; Liver; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2021 |
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Topics: Adolescent; Alanine Transaminase; Antioxidants; Bariatric Surgery; Child; Child, Preschool; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Diet; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Life Style; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pediatric Obesity; Vitamin E | 2020 |
Chronic liver disease and oxidative stress - a narrative review.
Topics: Animals; Antioxidants; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Dietary Supplements; Flavonoids; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Reactive Oxygen Species; Vitamin E | 2021 |
Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH.
Topics: Biopsy; Humans; Liver Cirrhosis; Network Meta-Analysis; Non-alcoholic Fatty Liver Disease; Pioglitazone; Vitamin E | 2021 |
Current and future pharmacologic treatment of nonalcoholic steatohepatitis.
Topics: Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; Inflammation; Liver Cirrhosis; Liver Neoplasms; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pioglitazone; Thiazolidinediones; Vitamin E | 2017 |
Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease.
Topics: Adolescent; Antioxidants; Child; Child, Preschool; Fibrosis; Humans; Infant; Life Style; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Vitamin E; Young Adult | 2017 |
Future therapy for non-alcoholic fatty liver disease.
Topics: Animals; Diet; Gastrointestinal Microbiome; Humans; Hypoglycemic Agents; Inflammation; Life Style; Liver Cirrhosis; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Thiazolidinediones; Vitamin E | 2018 |
Nonalcoholic Fatty Liver Disease and Obesity Treatment.
Topics: Bariatric Surgery; Body Weight; Diet; Exercise; Glucagon-Like Peptide 1; Humans; Inflammation; Insulin Resistance; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Prostatic Neoplasms; Vitamin E; Weight Loss | 2019 |
Diagnosis and management of non-alcoholic fatty liver disease.
Topics: Antioxidants; Diabetes Mellitus, Type 2; Disease Management; Elasticity Imaging Techniques; Exercise; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Magnetic Resonance Imaging; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Tomography, X-Ray Computed; Ultrasonography; Vitamin E; Weight Reduction Programs | 2019 |
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Topics: Anticholesteremic Agents; Antioxidants; Bariatric Surgery; Carcinoma, Hepatocellular; Disease Progression; Genetic Variation; Humans; Hypoglycemic Agents; Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Membrane Proteins; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Prognosis; Receptors, Cytoplasmic and Nuclear; Vitamin E | 2015 |
The therapeutic landscape of non-alcoholic steatohepatitis.
Topics: Antioxidants; Chalcones; Chenodeoxycholic Acid; Disease Progression; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Pioglitazone; Propionates; Randomized Controlled Trials as Topic; Thiazolidinediones; Vitamin E; Weight Loss | 2017 |
Therapies in non-alcoholic steatohepatitis (NASH).
Topics: Carcinoma, Hepatocellular; Diet; Disease Progression; Exercise; Fibrosis; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Non-alcoholic Fatty Liver Disease; Pioglitazone; Randomized Controlled Trials as Topic; Risk Factors; Thiazolidinediones; Vitamin E | 2017 |
Nonalcoholic fatty liver disease in children.
Topics: Child; Diet; Exercise; Fatty Liver; Genetic Predisposition to Disease; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Obesity; Prevalence; Vitamin E | 2011 |
[Fatty liver and its clinical management in obese adolescents].
Topics: Adiponectin; Adolescent; Apoptosis; Biomarkers; Chemokines; Disease Progression; Fatty Liver; Fibrosis; Hepatocytes; Humans; Hypertriglyceridemia; Insulin Resistance; Kupffer Cells; Liver Cirrhosis; Liver Transplantation; Metformin; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2011 |
Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
Topics: Betaine; Cytokines; Dietary Supplements; Environmental Exposure; Fatty Liver; Female; Humans; Insulin Resistance; Life Style; Liver; Liver Cirrhosis; Metabolic Syndrome; Methionine; Middle Aged; Mitochondrial Diseases; Oxidative Stress; S-Adenosylmethionine; United States; Vitamin E; Xenobiotics; Zinc | 2007 |
Vitamin E in chronic liver diseases and liver fibrosis.
Topics: Animals; Antioxidants; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Vitamin E | 2007 |
Iron and the liver.
Topics: Ascorbic Acid; Carcinoma, Hepatocellular; Collagen; Free Radicals; Hemochromatosis; Humans; Iron; Liver; Liver Cirrhosis; Liver Neoplasms; Lysosomes; Membrane Potentials; Porphyrias; Potassium; Transferrin; Uroporphyrins; Vitamin E | 1991 |
18 trial(s) available for d-alpha tocopherol and Liver Cirrhosis
| Article | Year |
|---|---|
Phytochemicals in hepatocellular cancer prevention.
Topics: alpha-Tocopherol; Animals; Anticarcinogenic Agents; beta Carotene; Carcinoma, Hepatocellular; Carotenoids; Cryptoxanthins; Dietary Supplements; Hepatitis, Viral, Human; Humans; Inositol; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Lycopene; Male; Mice; Mice, Inbred C3H; Tumor Burden; Xanthophylls | 2009 |
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Topics: Adult; alpha-Tocopherol; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Female; France; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; RNA, Viral; Time Factors; Treatment Outcome | 2010 |
Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.
Topics: Alanine Transaminase; alpha-Fetoproteins; alpha-Tocopherol; Antioxidants; Carcinoma, Hepatocellular; Cholesterol; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Platelet Count; Serum Albumin; Survival Rate | 2003 |
Prevention of hepatocellular carcinoma in chronic viral hepatitis patients with cirrhosis by carotenoid mixture.
Topics: alpha-Tocopherol; Carcinoma, Hepatocellular; Carotenoids; Female; Hepatitis C; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 2007 |
Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Alanine Transaminase; alpha-Tocopherol; Antioxidants; Carica; Deoxyguanosine; DNA Damage; Female; Fermentation; Fruit; Glutathione; Glutathione Peroxidase; Hepatitis C; Humans; Immunologic Factors; Liver Cirrhosis; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Plant Preparations; Receptors, Tumor Necrosis Factor, Type II; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; alpha-Tocopherol; Aspartate Aminotransferases; Body Weight; Cholesterol; Fatty Liver; Female; gamma-Glutamyltransferase; Hepatitis; Humans; Liver Cirrhosis; Male; Pilot Projects; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triglycerides | 2001 |
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.
Topics: Biopsy; Fibrosis; Humans; Inflammation; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Pioglitazone; Proteomics; Vitamin E | 2023 |
Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.
Topics: Adolescent; Area Under Curve; Biopsy; Child; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Logistic Models; Male; Metformin; Non-alcoholic Fatty Liver Disease; Odds Ratio; ROC Curve; Severity of Illness Index; Treatment Outcome; Vitamin E; Vitamins | 2021 |
Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
Topics: Adipokines; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Biopsy; Combined Modality Therapy; Dietary Supplements; Female; Humans; Hyperinsulinism; Insulin Resistance; Intention to Treat Analysis; Liver; Liver Cirrhosis; Male; Mineralocorticoid Receptor Antagonists; Non-alcoholic Fatty Liver Disease; Severity of Illness Index; Spironolactone; Ultrasonography; Vitamin E | 2017 |
Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in β-thalassemia major patients.
Topics: Adolescent; Antioxidants; Ascorbic Acid; beta-Thalassemia; Child; Child, Preschool; Female; Ferritins; Glutathione; Humans; Liver; Liver Cirrhosis; Male; Malondialdehyde; Prospective Studies; Superoxide Dismutase; Transaminases; Vitamin A; Vitamin E | 2013 |
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.
Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Biopsy, Needle; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fatty Liver; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Treatment Outcome; Vitamin E | 2003 |
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Topics: Adult; Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Biopsy; Body Mass Index; Diet, Reducing; Fatty Liver; Female; Follow-Up Studies; Hepatitis; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Metformin; Middle Aged; Treatment Outcome; Vitamin E | 2005 |
[Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Topics: Adult; Aged; Biomarkers; Drug Combinations; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Phospholipids; Pilot Projects; Silybin; Silymarin; Vitamin E | 2005 |
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
Topics: Adolescent; Adult; Aged; Biopsy; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Transaminases; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E; Vitamins | 2006 |
Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation.
Topics: Aged; Blood Platelets; Dietary Supplements; Double-Blind Method; Fatty Acids, Unsaturated; Female; gamma-Linolenic Acid; Humans; Linoleic Acid; Lipids; Liver Cirrhosis; Male; Membrane Lipids; Middle Aged; Oleic Acid; Platelet Aggregation; Reference Values; Thromboxane A2; Vitamin E | 1998 |
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients.
Topics: Adult; Aged; Cross-Sectional Studies; Dietary Supplements; Dinoprost; Female; Humans; In Vitro Techniques; Lipid Peroxidation; Lipopolysaccharides; Liver Cirrhosis; Male; Middle Aged; Monocytes; Peptide Fragments; Placebos; Protein Precursors; Prothrombin; Reference Values; Thromboplastin; Vitamin E | 1999 |
Normothermic liver ischemia and antioxidant treatment during hepatic resections.
Topics: Antioxidants; Ascorbic Acid; Humans; Lipid Peroxidation; Liver; Liver Cirrhosis; Malondialdehyde; Postoperative Complications; Prothrombin Time; Reperfusion Injury; Temperature; Thiobarbituric Acid Reactive Substances; Time Factors; Transaminases; Vitamin E | 1999 |
Vitamin E and cirrhotic muscle cramps.
Topics: Adult; Aged; Electromyography; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Muscle Cramp; Vitamin E | 1991 |
69 other study(ies) available for d-alpha tocopherol and Liver Cirrhosis
| Article | Year |
|---|---|
t(1;22)(p13;q13) Acute Megakaryoblastic Leukemia Complicated by Hepatic Fibrosis: Antifibrosis Therapy?
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Child, Preschool; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 22; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Keratolytic Agents; Leukemia, Megakaryoblastic, Acute; Liver Cirrhosis; Prognosis; Translocation, Genetic; Tretinoin | 2021 |
Hepatic effects of rosiglitazone in rats with the metabolic syndrome.
Topics: Adiponectin; alpha-Tocopherol; Animal Feed; Animals; Aryldialkylphosphatase; Blood Pressure; Fatty Liver; Fructose; Glutathione Reductase; Hypoglycemic Agents; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Male; Malondialdehyde; Metabolic Syndrome; Phospholipids; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2010 |
The influence of cholene cystine, and of alpha-tocopherol upon the occurrence of ceroid pigment in dietary cirrhosis of rats.
Topics: alpha-Tocopherol; Animals; Ceroid; Cholenes; Cystine; Liver Cirrhosis; Pigments, Biological; Rats | 1945 |
Additive effect of alpha-tocopherol and ascorbic acid in combating ethanol-induced hepatic fibrosis.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Biomarkers; Chromatography, High Pressure Liquid; Collagen Type I; Drug Therapy, Combination; Ethanol; Inflammation; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor alpha; Tumor Necrosis Factor-alpha | 2013 |
Arachidonic acid in mononuclear cells and its clinical significance in HCV cirrhotic patients.
Topics: Aged; alpha-Tocopherol; Arachidonic Acid; Carcinoma, Hepatocellular; Case-Control Studies; Chromatography, Gas; Chromatography, High Pressure Liquid; Disease Progression; Enzyme-Linked Immunosorbent Assay; Fatty Acids; Female; Hepatitis C; Humans; Leukocytes, Mononuclear; Liver Cirrhosis; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Phospholipids; Platelet Count; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2003 |
[Findings on the effect of orotic acid on protein metabolism; initial data on its use in combination with alpha-tocopherol in cases of chronic liver diseases].
Topics: alpha-Tocopherol; Blood Proteins; Enzymes; Humans; Liver Cirrhosis; Liver Diseases; Orotic Acid; Proteins; Vitamin E | 1957 |
[Behavior of blood ketones in chronic decompensated liver diseases during treatment with potassium orotate & alpha-tocopherol].
Topics: alpha-Tocopherol; Humans; Keto Acids; Ketones; Liver Cirrhosis; Liver Diseases; Orotic Acid; Vitamin E | 1957 |
Reduced serum concentrations of retinol and alpha-tocopherol and high concentrations of hydroperoxides are associated with community levels of S. mansoni infection and schistosomal periportal fibrosis in Ethiopian school children.
Topics: Adolescent; alpha-Tocopherol; Animals; Child; Child Nutrition Disorders; Cross-Sectional Studies; Ethiopia; Feces; Female; Humans; Lipid Peroxides; Liver; Liver Cirrhosis; Male; Portal Vein; Prevalence; Schistosoma mansoni; Schistosomiasis mansoni; Ultrasonography; Vitamin A | 2007 |
Habitual food intake and polyunsaturated fatty acid deficiency in liver cirrhosis.
Topics: Alanine Transaminase; alpha-Tocopherol; Antioxidants; Eating; Fatty Acids, Unsaturated; Feeding Behavior; Female; Humans; Japan; Liver Cirrhosis; Male; Middle Aged; Surveys and Questionnaires | 2002 |
Impaired vitamin E status in patients with parenchymal liver cirrhosis: relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma.
Topics: Adult; Aged; alpha-Tocopherol; Cholesterol; Chromatography, High Pressure Liquid; Copper; Female; Humans; Lipid Peroxidation; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Liver; Liver Cirrhosis; Male; Middle Aged; Nutritional Status; Oxidation-Reduction; Vitamin E | 2002 |
Evidence of oxidative imbalance in long-term liver transplant patients.
Topics: Adult; alpha-Tocopherol; Cross-Sectional Studies; Female; Humans; Lipid Peroxidation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Oxidative Stress; Postoperative Period; Thiobarbituric Acid Reactive Substances | 2002 |
Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient-reported quality of life.
Topics: Fibrosis; Humans; Ligands; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Patient Reported Outcome Measures; Pioglitazone; Quality of Life; Vitamin E | 2022 |
Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
Topics: Animals; Carbon Tetrachloride; Fibrosis; Liver; Liver Cirrhosis; Mice; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Transcription Factors; Transforming Growth Factor beta; Vitamin E | 2022 |
Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Bariatric Surgery; Biopsy; Diet, Reducing; Elasticity Imaging Techniques; Exercise; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Referral and Consultation; Risk Assessment; Serum Albumin; Severity of Illness Index; Thiazolidinediones; Vitamin E; Vitamins | 2020 |
Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl
Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Coculture Techniques; Hepatocytes; Liver Cirrhosis; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Vitamin E; Wharton Jelly | 2021 |
Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand.
Topics: Carcinoma, Hepatocellular; Cost-Benefit Analysis; Humans; Hypoglycemic Agents; Liver Cirrhosis; Liver Neoplasms; Markov Chains; Middle Aged; Non-alcoholic Fatty Liver Disease; Pioglitazone; Quality-Adjusted Life Years; Thailand; Vitamin E; Weight Loss; Weight Reduction Programs | 2019 |
Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis.
Topics: Disease-Free Survival; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Severity of Illness Index; Vitamin E; Vitamins | 2020 |
Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.
Topics: Adult; Biopsy; Chenodeoxycholic Acid; Female; Humans; Hypoglycemic Agents; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pioglitazone; Randomized Controlled Trials as Topic; Receptors, Cytoplasmic and Nuclear; Retrospective Studies; Treatment Outcome; Vitamin E; Vitamins | 2019 |
Potential antifibrotic and angiostatic impact of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury.
Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Antioxidants; Aspartate Aminotransferases; Carnosine; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Glutathione Transferase; Hep G2 Cells; Humans; Liver Cirrhosis; Male; Mice; Nitrates; Nitrites; Smad2 Protein; Titanium; Transforming Growth Factor beta; Ubiquinone; Vascular Endothelial Growth Factor A; Vitamin E | 2015 |
Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.
Topics: Animals; Antioxidants; Choline; Cytokines; Diet; Gene Expression; Glutathione; Hepatic Stellate Cells; Hepatitis; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinases; Methionine; Mice; Mice, Inbred C57BL; Pyrrolidonecarboxylic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidines; Thiobarbituric Acid Reactive Substances; Time Factors; Tissue Inhibitor of Metalloproteinases; Vitamin E | 2009 |
A pilot study of vitamin E for the treatment of cirrhotic muscle cramps.
Topics: Adult; Double-Blind Method; Humans; Liver Cirrhosis; Middle Aged; Muscle Cramp; Pilot Projects; Random Allocation; Vitamin E | 2011 |
Vitamin E reduces hepatic fibrosis in mice with Schistosoma japonicum infection.
Topics: Animals; Catalase; Collagen Type III; Collagen Type IV; Female; Glutathione Peroxidase; Hyaluronic Acid; Laminin; Liver; Liver Cirrhosis; Malondialdehyde; Mice; Schistosoma japonicum; Schistosomiasis japonica; Superoxide Dismutase; Vitamin E; Vitamins | 2012 |
[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis].
Topics: Fatty Liver; Humans; Hypoglycemic Agents; Liver Cirrhosis; Liver Neoplasms; Pioglitazone; Prognosis; Risk Factors; Thiazolidinediones; Vitamin E | 2012 |
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
Topics: Alcohol Drinking; Bariatric Surgery; Biopsy; Child; Disease Management; Fatty Liver; Fatty Liver, Alcoholic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Incidence; Liver Cirrhosis; Mass Screening; Non-alcoholic Fatty Liver Disease; Prevalence; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; United States; Vitamin E; Weight Loss | 2012 |
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
Topics: Combined Modality Therapy; Cost-Benefit Analysis; Fatty Liver; Humans; Hypoglycemic Agents; Life Style; Liver Cirrhosis; Markov Chains; Non-alcoholic Fatty Liver Disease; Pioglitazone; Quality-Adjusted Life Years; Severity of Illness Index; Thiazolidinediones; Vitamin E; Vitamins | 2012 |
Green tea extract supplementation ameliorates CCl4-induced hepatic oxidative stress, fibrosis, and acute-phase protein expression in rat.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; beta Carotene; Bile; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Female; Hydroxyproline; Lipid Metabolism; Liver Cirrhosis; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reactive Oxygen Species; Tea; Vitamin E | 2012 |
Effects of vitamin E on the proliferation and collagen synthesis of rat hepatic stellate cells treated with IL-2 or TNF-alpha.
Topics: Animals; Cell Division; Cells, Cultured; Collagen; Interleukin-2; Liver; Liver Cirrhosis; Microscopy, Phase-Contrast; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vitamin E | 2003 |
[THE EFFECT OF MAGNESIUM AND VITAMIN E ON THE ACUTE CARBON TETRACHLORIDE DAMAGE OF THE RAT LIVER].
Topics: Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Hepatitis; Liver Cirrhosis; Liver Cirrhosis, Experimental; Magnesium; Rats; Research; Vitamin E | 1963 |
[Plasma levels of ascorbic acid and vitamin E in patients with liver cirrhosis].
Topics: Adult; Aged; Aged, 80 and over; Ascorbic Acid; Female; Humans; Lipid Peroxides; Liver Cirrhosis; Male; Middle Aged; Vitamin E | 2003 |
Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Cholestasis, Intrahepatic; Collagen; Glutathione; Lipid Peroxidation; Liver Cirrhosis; Male; Oxidative Stress; Rats; Rats, Wistar; Silymarin; Vitamin E | 2004 |
The absorption and excretion of tocopherol in Laennec's cirrhosis.
Topics: Biological Transport; Body Fluids; Humans; Liver Cirrhosis; Quinolines; Tocopherols; Vitamin E | 1952 |
The role of vitamin E and C therapy in NASH.
Topics: Analysis of Variance; Antioxidants; Ascorbic Acid; Biopsy, Needle; Dietary Supplements; Fatty Liver; Female; Humans; Liver Cirrhosis; Male; Probability; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vitamin E | 2004 |
Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Antioxidants; Ascorbic Acid; Biomarkers; Biopsy; Cohort Studies; Dietary Supplements; Female; Glutathione; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Severity of Illness Index; Viral Load; Vitamin E | 2005 |
Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.
Topics: Animals; Antioxidants; Biological Availability; Drug Combinations; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Silymarin; Tissue Inhibitor of Metalloproteinase-1; Vitamin E | 2005 |
Intestinal mucosal alterations in rats with carbon tetrachloride-induced cirrhosis: changes in glycosylation and luminal bacteria.
Topics: Animals; Antioxidants; Bacteria; Bacterial Adhesion; Carbohydrate Metabolism; Carbon Tetrachloride; Female; Glycosylation; Hydrophobic and Hydrophilic Interactions; Intestinal Mucosa; Liver Cirrhosis; Male; Microvilli; Oxidative Stress; Rats; Rats, Wistar; Tissue Distribution; Tungsten Compounds; Vitamin E; Xanthine Oxidase | 2006 |
Relationship between oxidative stress levels and activation state on a hepatic stellate cell line.
Topics: Acetylcysteine; Animals; Antioxidants; Catalase; Cell Line; Cell Proliferation; Chromans; Cytokines; Liver; Liver Cirrhosis; Mice; Oxidative Stress; Phenotype; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Vitamin E | 2006 |
Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
Topics: Adult; Aged; Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Biopsy; Body Mass Index; Diet, Reducing; Fatty Liver; Female; Hepatitis; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Metformin; Middle Aged; Treatment Outcome; Vitamin E | 2006 |
Antioxidants vitamin E and C attenuate hepatic fibrosis in biliary-obstructed rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Cholestasis; Collagen; Drug Synergism; Female; Hyaluronic Acid; Ligation; Liver Cirrhosis; Liver Cirrhosis, Biliary; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Vitamin E | 2006 |
Protein glutathionylation increases in the liver of patients with non-alcoholic fatty liver disease.
Topics: Adolescent; Antioxidants; Child; Child, Preschool; Collagen Type VI; Fatty Liver; Female; Glutathione; Hepatocytes; Humans; Liver; Liver Cirrhosis; Male; Oxidative Stress; Proteins; Vitamin E | 2008 |
[Clinical aspects of essential fatty acids].
Topics: Animals; Cell Membrane Permeability; Cholesterol; Coronary Disease; Fatty Acids, Essential; Fatty Liver; Humans; Linoleic Acids; Liver Cirrhosis; Liver Diseases; Malabsorption Syndromes; Nutrition Disorders; Proteins; Rats; Vitamin E | 1967 |
Reversible visual evoked potential abnormalities in vitamin E deficiency.
Topics: Adult; Brain Stem; Cystic Fibrosis; Electroretinography; Evoked Potentials, Visual; Female; Humans; Liver Cirrhosis; Vitamin A Deficiency; Vitamin E; Vitamin E Deficiency | 1984 |
alpha-Tocopherol level in liver diseases.
Topics: Adolescent; Adult; Cholesterol; Hepatitis; Hepatitis, Alcoholic; Humans; Lipoproteins, LDL; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Middle Aged; Phospholipids; Vitamin E | 1982 |
The therapeutic benefit of vitamin E in patients with liver disease.
Topics: Humans; Liver Cirrhosis; Muscle Cramp; Vitamin E | 1994 |
A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency.
Topics: Alanine Transaminase; Bile Acids and Salts; Bilirubin; Child; Child, Preschool; Cholestasis, Intrahepatic; Cholesterol; Follow-Up Studies; gamma-Glutamyltransferase; Hepatitis; Humans; Infant; Liver; Liver Cirrhosis; Multienzyme Complexes; Progesterone Reductase; Retrospective Studies; Steroid Isomerases; Ursodeoxycholic Acid; Vitamin E | 1994 |
Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress.
Topics: Biomarkers; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Coenzymes; Electrochemistry; Hepatitis; Hexanes; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Solvents; Ubiquinone; Vitamin E | 1997 |
Enhanced lipid peroxidation in hepatic cirrhosis.
Topics: Adult; Aged; Antioxidants; Case-Control Studies; Dinoprost; F2-Isoprostanes; Female; Humans; Lipid Peroxidation; Liver Cirrhosis; Male; Middle Aged; Vitamin E | 1998 |
Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; beta Carotene; Biomarkers; Carcinoma, Hepatocellular; Carotenoids; Cholesterol; Cholesterol Esters; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Lycopene; Male; Middle Aged; Oxidative Stress; Ubiquinone; Vitamin E | 1998 |
Vitamin E status in patients with liver cirrhosis: normal or deficient?
Topics: Adult; Aged; Cholesterol; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Vitamin E | 1999 |
Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Ascorbic Acid; beta Carotene; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Carotenoids; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Neoplasms; Lycopene; Male; Middle Aged; Oxidative Stress; Reference Values; Ubiquinone; Uric Acid; Vitamin E | 1999 |
Oxidative stress effect on the activation of hepatic stellate cells.
Topics: Actins; Animals; Cells, Cultured; Extracellular Matrix Proteins; Liver; Liver Cirrhosis; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vitamin E | 2001 |
The protective effect of vitamin E on gastric mucosal injury in rats with cirrhosis of the liver.
Topics: Animals; Antioxidants; Carbon Tetrachloride Poisoning; Gastric Mucosa; Liver Cirrhosis; Male; Malondialdehyde; Rats; Vitamin E | 1999 |
Oxidative stress in chronic hepatitis C: not just a feature of late stage disease.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Dinoprost; F2-Isoprostanes; Female; Glutathione; Hepatitis C, Chronic; Humans; Lipid Peroxidation; Liver Cirrhosis; Male; Middle Aged; Oxidative Stress; Selenium; Vitamin A; Vitamin E | 2002 |
Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorouracil; Humans; Indomethacin; Kinetics; Liver Cirrhosis; Liver Neoplasms; Microsomes, Liver; Nicotinic Acids; Tegafur; Vitamin E | 1979 |
[Changes of some vitamin levels in plasma in patients with chronic liver diseases].
Topics: Ascorbic Acid; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Vitamin E | 1975 |
Vitamin E deficiency and platelet functional defect in a jaundiced infant.
Topics: Blood Platelet Disorders; Hemostasis; Humans; Infant; Jaundice; Liver Cirrhosis; Male; Osmotic Fragility; Platelet Aggregation; Vitamin E; Vitamin E Deficiency | 1975 |
Liver fibrosis in a patient with familial homozygous hypobetalipoproteinaemia: possible role of vitamin supplementation.
Topics: Adult; Female; Homozygote; Humans; Hypobetalipoproteinemias; Liver Cirrhosis; Vitamin A; Vitamin E | 1992 |
Carotenoids and liposoluble vitamins in liver cirrhosis.
Topics: Carotenoids; Chromatography, High Pressure Liquid; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Vitamin A; Vitamin E | 1991 |
[Clinical study of vitamin E status in patients with chronic liver diseases].
Topics: Chronic Disease; Female; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Vitamin E | 1991 |
[Importance of the determination of lipid peroxidation in portal liver cirrhosis].
Topics: Adult; Glutathione Peroxidase; Humans; Lipid Peroxides; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Oxidation-Reduction; Selenium; Vitamin E | 1987 |
Selenium status in patients with liver cirrhosis and alcoholism.
Topics: Adult; Aged; Alcoholism; Female; Humans; Lipid Peroxides; Liver Cirrhosis; Male; Middle Aged; Nutritional Status; Selenium; Vitamin A; Vitamin E | 1986 |
[Lipid peroxidation and antioxidants in the blood of patients with liver cirrhosis and iron-deficiency anemia].
Topics: Adult; Alkadienes; Anemia, Hypochromic; Antioxidants; Glutathione; Humans; Lipid Peroxides; Liver Cirrhosis; Malondialdehyde; Middle Aged; Oxidation-Reduction; Vitamin E | 1985 |
Pharmacology of fibrosis and tissue injury.
Topics: Aminopropionitrile; Animals; Asbestos; Collagen; Culture Techniques; Disease Models, Animal; Erythrocytes; Hemolysis; Liver Cirrhosis; Macrophages; Mice; Phagocytosis; Phenanthrolines; Pulmonary Fibrosis; Quartz; Rats; Silicon Dioxide; Vitamin E; Zinc | 1974 |
Vitamin E protection of the liver from paracetamol in the rat.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Female; Liver; Liver Cirrhosis; Rats; Vitamin E; Vitamin E Deficiency | 1974 |
Low plasma tocopherol levels in patients with gastrointestinal disorders.
Topics: Adult; Aged; Alkaline Phosphatase; Celiac Disease; Cholesterol; Colitis, Ulcerative; Crohn Disease; Diverticulum, Colon; Feces; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Lipids; Liver Cirrhosis; Malabsorption Syndromes; Middle Aged; Pancreatitis; Peptic Ulcer; Protein-Losing Enteropathies; Time Factors; Vitamin E; Vitamin E Deficiency | 1973 |
Relationship of serum tocopherol to beta-lipoprotein concentrations in liver diseases.
Topics: Diet; Hepatitis; Humans; Lipoproteins; Liver Cirrhosis; Liver Diseases; Vitamin E | 1970 |
The absorption of alpha-tocopherol in man.
Topics: Celiac Disease; Fasting; Feces; Gastrectomy; Humans; Intestinal Absorption; Liver Cirrhosis; Tritium; Vitamin E; Vitamin E Deficiency | 1970 |
Structure--activity relations in the vitamin E series. II. Derivatives of alpha-tocopherol substituted at the 5-methyl group.
Topics: Acetates; Animals; Chemical Phenomena; Chemistry; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Muscular Dystrophies; Quinones; Rabbits; Rats; Vitamin E; Vitamin E Deficiency | 1969 |
Interrelation of serum lipoprotein and tocopherol levels.
Topics: Arteries; Blood Protein Electrophoresis; Cardiovascular Diseases; Cholesterol; Chromatography, Thin Layer; Female; Hepatitis; Humans; Hyperthyroidism; Hypothyroidism; Lipoproteins; Liver Cirrhosis; Malabsorption Syndromes; Pregnancy; Vitamin E | 1969 |
[Experimental clinical research on the therapeutic action of AM 65234].
Topics: Adolescent; Adult; Aged; Biliary Tract Diseases; Heart Diseases; Hepatitis A; Humans; Hypersplenism; Liver Cirrhosis; Liver Extracts; Lung Diseases; Middle Aged; Vitamin B 12; Vitamin E; Vitamin K 1 | 1966 |